The average P/S ratio for PPBT's competitors is 22.35, providing a benchmark for relative valuation. Purple Biotech Ltd Corp (PPBT) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.